Dopamine modification of glycolytic enzymes impairs glycolysis: possible implications for Parkinson’s disease

Abstract Background Parkinson’s disease (PD), a chronic and severe neurodegenerative disease, is pathologically characterized by the selective loss of nigrostriatal dopaminergic neurons. Dopamine (DA), the neurotransmitter produced by dopaminergic neurons, and its metabolites can covalently modify p...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Bing Chen, Qian Zhang, Xiaoru Zhong, Xinwei Zhang, Xin Liu, Hongyang Wang, Fan Yang, Jingjing Zhang, Jingnan Huang, Yin-Kwan Wong, Piao Luo, Jigang Wang, Jichao Sun
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	BMC 2024-01-01
Saila:	Cell Communication and Signaling
Gaiak:	Dopamine (DA) Parkinson’s disease (PD) Glycolysis Mitochondrial dysfunction
Sarrera elektronikoa:	https://doi.org/10.1186/s12964-024-01478-0
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!